Theralase(R) Completes Enrollment in Bladder Cancer Clinical Study
Go back to Theralase(R) Completes Enrollment in Bladder Cancer Clinical Study| Theralase Technologies Inc Ordinary Share (AMEX: TLTFF) | Delayed: 0.13 -0.01 (7.14%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $0.14 | 52 Week High | $0.35 | |||
| Open | $0.14 | 52 Week Low | $0.18 | |||
| Day High | $0.14 | P/E | N/A | |||
| Day Low | $0.13 | EPS | $0.00 | |||
| Volume | 360,286 | |||||
